Aryl and acyclic unsaturated derivatives of thioguanine and 6-mercaptopurine: Synthesis and cytotoxic activity

Letters in Drug Design and Discovery

Volumn 8, Issue 8, 2011, Pages 709-716

  Banh, Tien N ^a   Kode, Nageswara R ^a   Phadtare, Shashikant ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

6 Mercaptopurine; Cytotoxic activity; Substituted 6 mercaptopurine; Substituted thioguanine; Thioguanine

Indexed keywords

6 (4' CHLORO 2' BUTYNYL 1' YL)THIOGUANINE; 6 MERCAPTOPURINE DERIVATIVE; ACYCLIC HYDROCARBON SUBSTITUENT; BIS 6,9 (4' CHLORO 2' BUTYNYL 1' YL)THIOGUANINE; BIS 6,9 [4' CHLORO 2' BUTYNYL 1' YL)MERCAPTOPURINE; BIS 6,9 [[O(CHLOROMETHYL)PHENYL]METHYL]THIOGUANINE; THIOGUANINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN CANCER; CANCER CELL CULTURE; CELL SCREENING; COLON CANCER; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NATIONAL HEALTH ORGANIZATION; NERVOUS SYSTEM TUMOR; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 80051962599     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018011796576088     Document Type: Article

References (17)

1. Ellison, R. R.; Burchenal, J. H. Chemotherapy of Leukemia., CA Cancer J Clin., 1957, 7, 57-62.
2. Yuan, B.; Connor, T. R.; Wang, Y. 6-Thioguanine and S6-Methylthioguanine Are Mutagenic in Human Cells. ACS Chemical Biology. 2010, 5, 1021-1027.
3. Nelson, J. A.; Carpenter, J. W.; Rose, L. M.; Adamson D. J. Mechanisms of Action of 6-Thioguanine, 6-Mercaptopurine and 8-AzaGuanine. Cancer Research., 1975, 53, 2872-8.
4. LePage, G. A.; Jones, Maryanne. Further Studies on the Mechanism of Action of 6-Thioguanine. Cancer Research., 1961, 21, 1590-94.
5. Gunnarsdottir, S.; Rucki, M.; Phillips, L. A,; et al. The Glutathione-Activated Thiopurine Prodrugs trans-6-(2-Acetylvinylthio) guanine and cis-6-(2-Acetylvinylthio) purine Causes Less in vivo Toxicity than 6-Thioguanine after Single-and Multiple-Dose Regimens. Molecular Cancer Therapeutics., 2002, 1, 1211-1220.
6. Montgomery, J. A.; Johnston, T. P.; et al. A Comparative Study of the Anticancer Activity of Some S-Substituted Derivates of 6-Mercaptopyrine and Their Ribonucleosides., Journal of Medicinal and Pharmaceutical Chemistry., 1961, 3, 265-288.
7. Giner-Sorolla, A.; Bendich, A. The Synthesis and Properties of 6-Mercaptomethulpurine and Derivates. Journal of Medicinal Chemistry. 1965, 8, 667-672.
8. Temple, C.; Kussner, C. L.; Montgomery, J. A. Lipid Soluble Derivatives of 6-Mercaptopurine. Journal of Medicinal Chemistry., 1968, 11, 41-44.
9. Montgomery, J. A. The Relation of Anticancer Activity to Chemical Structure. Cancer Research., 1959, 19, 447-463.
10. Miron, T.; Arditti, F.; Konstantinovski, L.; et al. Novel Derivates of 6-Mercaptopurine: Synthesis, Characterization and Antiproliferative Activities of S-Allylthio-Mercaptopurines. European Journal of Medicinal Chemistry., 2009, 44, 541-550.
11. Gunnarsdottir, S.; Elfarra, A. Cytotoxicity of the Novel Glutathione-Activated Thiopurine Prodrugs cis-AVTP [cis-6-(2-Acetylvinylthio) Purine] and trans-AVTG [trans-6-(2-Acetylvinylthio) Guanine] Results from the National Cancer Institute's Anticancer Drug Screen. Drug Metabolism and Disposition. 2004, 32, 321-327. (Pubitemid 38263890)
12. Dubinsky, Marla. Azathioprine, 6-Mercaptopurine in Inflammatory Bowel Disease: Pharmacology, Efficacy, and Safety. Clinical Gastroenterology and Hepatology. 2004, 2, 731-743. (Pubitemid 39200711)
13. Murthy, D.; Brakta.; Ellis, L.; Abanah, O.; and Phadtare, S. Med. Chem. Research 2003, 12, 13-25.
14. Alley, M. C.; Scudiero, D. A.; Monks, P. A.; Hursey, M. L.; Czerwinski, M. J.; Fine, D. L.; Abbott, B. J., Mayo, J. G.; Shoemaker, R. H.; and Boyd, M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Research 1988, 48, 589-601. (Pubitemid 18056527)
15. Grever, M. R.; Schepartz, S. A.; and Chabner, B. A. The national Cancer Institute: Cancer drug discovery and development program. Seminars in Oncology, 1992, 6, 622-638. (Pubitemid 23004840)
16. Boyd, M. R.; and Paul, K. D. Some practical considerations and applications of the National Cancer Institute Invitro Anticancer Drug Discovery Screen. Drug Development Research, 1995, 34, 91-109.
17. Shoemaker, R. H. The NCI 60 Human Tumor Cell line Anti Cancer Drug Screen. Nature Reviews, 2006, 6, 813-823. (Pubitemid 44450469)